RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,556,380 | -33.0% | 185,063 | 0.0% | 0.56% | -32.2% |
| Q2 2023 | $2,324,391 | -23.7% | 185,063 | 0.0% | 0.82% | -29.6% |
| Q1 2023 | $3,047,988 | +10.2% | 185,063 | 0.0% | 1.17% | +2.3% |
| Q4 2022 | $2,764,841 | -33.2% | 185,063 | 0.0% | 1.14% | -34.5% |
| Q3 2022 | $4,140,000 | +33.5% | 185,063 | 0.0% | 1.75% | +30.7% |
| Q2 2022 | $3,100,000 | -44.0% | 185,063 | 0.0% | 1.34% | -31.3% |
| Q1 2022 | $5,539,000 | -2.5% | 185,063 | 0.0% | 1.94% | +4.6% |
| Q4 2021 | $5,683,000 | -2.6% | 185,063 | 0.0% | 1.86% | -7.3% |
| Q3 2021 | $5,835,000 | -13.8% | 185,063 | 0.0% | 2.00% | -10.5% |
| Q2 2021 | $6,771,000 | +5.8% | 185,063 | 0.0% | 2.24% | -4.8% |
| Q1 2021 | $6,398,000 | -7.1% | 185,063 | +11.7% | 2.35% | -13.3% |
| Q4 2020 | $6,884,000 | -2.4% | 165,639 | 0.0% | 2.71% | -18.6% |
| Q3 2020 | $7,055,000 | – | 165,639 | – | 3.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |